A prospective surveillance study of inhibitor development in haemophilia A patients following a population switch to a third‐generation B‐domain‐deleted recombinant factor VIII. - Dubé, E.; Bonnefoy, A.; Merlen, C.; Rivard, G.‐É.; St‐Louis, J.; Castilloux, J.‐F.; Cloutier, S.; Demers, C.; Sabapathy, C. A.; Vezina, C.; Warner, M. (Haemophilia, 2018)